Elmiron 100 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DB25FW9C6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,327
Award facts
- Contract value 100% obligated
- $10,326.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,326.72 to AmerisourceBergen Drug Corp for 100 capsules of Elmiron 100 mg, with an ultimate completion date of September 19, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and specifies Conshohocken, Pennsylvania as the place of performance. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which holds a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, demonstrates significant capacity to fulfill federal medical procurement requirements through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The company's contract awards with the Defense Logistics Agency reflect its critical role in supporting military and veteran healthcare systems, with delivery orders consistently utilizing firm fixed pricing across a broad spectrum of pharmaceutical products and therapeutic domains. This particular delivery order for Elmiron, a medication used to treat interstitial cystitis, exemplifies the company's role in supplying specialized pharmaceutical products to support federal medical supply chain operations.
Quick answers
Who was awarded contract SPE2DB25FW9C6?
SPE2DB25FW9C6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FW9C6 worth?
The government has obligated $10,327 on SPE2DB25FW9C6.
Is contract SPE2DB25FW9C6 an order under another contract?
Yes. SPE2DB25FW9C6 is a delivery order under SPE2DB20D3304, an indefinite delivery contract.
Was contract SPE2DB25FW9C6 competed?
The extent of competition for SPE2DB25FW9C6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award